nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—Topoisomerase Inhibitors—Doxorubicin—kidney cancer	0.39	1	CiPCiCtD
Mitoxantrone—sarcoma—kidney cancer	0.235	1	CtDrD
Mitoxantrone—ABCB1—kidney cancer	0.05	1	CbGaD
Mitoxantrone—CYP1B1—Erlotinib—kidney cancer	0.0157	0.077	CbGbCtD
Mitoxantrone—CYP1B1—Paclitaxel—kidney cancer	0.0144	0.0705	CbGbCtD
Mitoxantrone—ABCC1—Dactinomycin—kidney cancer	0.0143	0.0701	CbGbCtD
Mitoxantrone—ABCG2—Pazopanib—kidney cancer	0.0105	0.0513	CbGbCtD
Mitoxantrone—ABCC1—Paclitaxel—kidney cancer	0.0102	0.0501	CbGbCtD
Mitoxantrone—TOP2A—Doxorubicin—kidney cancer	0.00993	0.0487	CbGbCtD
Mitoxantrone—ABCG2—Dactinomycin—kidney cancer	0.00957	0.0469	CbGbCtD
Mitoxantrone—ABCC1—Vinblastine—kidney cancer	0.00896	0.0439	CbGbCtD
Mitoxantrone—ABCC1—Vincristine—kidney cancer	0.00881	0.0432	CbGbCtD
Mitoxantrone—CYP1B1—Doxorubicin—kidney cancer	0.00775	0.038	CbGbCtD
Mitoxantrone—ABCG2—Erlotinib—kidney cancer	0.00747	0.0366	CbGbCtD
Mitoxantrone—ABCB1—Temsirolimus—kidney cancer	0.00718	0.0352	CbGbCtD
Mitoxantrone—ABCG2—Paclitaxel—kidney cancer	0.00684	0.0335	CbGbCtD
Mitoxantrone—CYP3A4—Everolimus—kidney cancer	0.00637	0.0312	CbGbCtD
Mitoxantrone—ABCG2—Sorafenib—kidney cancer	0.00607	0.0298	CbGbCtD
Mitoxantrone—ABCG2—Vincristine—kidney cancer	0.00589	0.0289	CbGbCtD
Mitoxantrone—ABCC1—Doxorubicin—kidney cancer	0.00551	0.027	CbGbCtD
Mitoxantrone—ABCG2—Sunitinib—kidney cancer	0.00492	0.0241	CbGbCtD
Mitoxantrone—CYP3A4—Temsirolimus—kidney cancer	0.0043	0.0211	CbGbCtD
Mitoxantrone—ABCB1—Pazopanib—kidney cancer	0.00377	0.0185	CbGbCtD
Mitoxantrone—ABCG2—Doxorubicin—kidney cancer	0.00368	0.0181	CbGbCtD
Mitoxantrone—ABCB1—Dactinomycin—kidney cancer	0.00345	0.0169	CbGbCtD
Mitoxantrone—ABCB1—Gemcitabine—kidney cancer	0.00273	0.0134	CbGbCtD
Mitoxantrone—ABCB1—Erlotinib—kidney cancer	0.00269	0.0132	CbGbCtD
Mitoxantrone—ABCB1—Paclitaxel—kidney cancer	0.00246	0.0121	CbGbCtD
Mitoxantrone—CYP3A4—Pazopanib—kidney cancer	0.00226	0.0111	CbGbCtD
Mitoxantrone—ABCB1—Sorafenib—kidney cancer	0.00219	0.0107	CbGbCtD
Mitoxantrone—ABCB1—Vinblastine—kidney cancer	0.00216	0.0106	CbGbCtD
Mitoxantrone—ABCB1—Vincristine—kidney cancer	0.00213	0.0104	CbGbCtD
Mitoxantrone—ABCB1—Sunitinib—kidney cancer	0.00177	0.00869	CbGbCtD
Mitoxantrone—CYP3A4—Erlotinib—kidney cancer	0.00161	0.00791	CbGbCtD
Mitoxantrone—CYP3A4—Paclitaxel—kidney cancer	0.00148	0.00724	CbGbCtD
Mitoxantrone—ABCB1—Doxorubicin—kidney cancer	0.00133	0.00651	CbGbCtD
Mitoxantrone—CYP3A4—Sorafenib—kidney cancer	0.00131	0.00643	CbGbCtD
Mitoxantrone—CYP3A4—Vinblastine—kidney cancer	0.0013	0.00635	CbGbCtD
Mitoxantrone—CYP3A4—Vincristine—kidney cancer	0.00127	0.00624	CbGbCtD
Mitoxantrone—SLC47A2—renal system—kidney cancer	0.0011	0.0811	CbGeAlD
Mitoxantrone—SLC47A2—kidney—kidney cancer	0.00107	0.0784	CbGeAlD
Mitoxantrone—CYP3A4—Sunitinib—kidney cancer	0.00106	0.00521	CbGbCtD
Mitoxantrone—SLC47A2—cortex of kidney—kidney cancer	0.00104	0.0764	CbGeAlD
Mitoxantrone—CYP3A4—Doxorubicin—kidney cancer	0.000796	0.0039	CbGbCtD
Mitoxantrone—PIM1—nephron tubule—kidney cancer	0.000792	0.0583	CbGeAlD
Mitoxantrone—CYP2E1—urine—kidney cancer	0.000745	0.0548	CbGeAlD
Mitoxantrone—PIM1—renal system—kidney cancer	0.00072	0.053	CbGeAlD
Mitoxantrone—PIM1—kidney—kidney cancer	0.000696	0.0512	CbGeAlD
Mitoxantrone—PIM1—cortex of kidney—kidney cancer	0.000678	0.0499	CbGeAlD
Mitoxantrone—PIM1—cardiac atrium—kidney cancer	0.000645	0.0475	CbGeAlD
Mitoxantrone—CYP3A4—urine—kidney cancer	0.0006	0.0441	CbGeAlD
Mitoxantrone—SLC47A1—nephron tubule—kidney cancer	0.000425	0.0312	CbGeAlD
Mitoxantrone—SLC47A1—renal system—kidney cancer	0.000386	0.0284	CbGeAlD
Mitoxantrone—SLC47A1—kidney—kidney cancer	0.000373	0.0274	CbGeAlD
Mitoxantrone—SLC47A1—cortex of kidney—kidney cancer	0.000363	0.0267	CbGeAlD
Mitoxantrone—SLC47A1—gonad—kidney cancer	0.000346	0.0255	CbGeAlD
Mitoxantrone—CYP1B1—nephron tubule—kidney cancer	0.000311	0.0229	CbGeAlD
Mitoxantrone—CYP1B1—renal system—kidney cancer	0.000283	0.0208	CbGeAlD
Mitoxantrone—CYP1B1—kidney—kidney cancer	0.000274	0.0201	CbGeAlD
Mitoxantrone—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.000269	0.227	CbGdCrCtD
Mitoxantrone—CYP1B1—cortex of kidney—kidney cancer	0.000266	0.0196	CbGeAlD
Mitoxantrone—CYP1B1—gonad—kidney cancer	0.000254	0.0187	CbGeAlD
Mitoxantrone—ABCC1—cortex of kidney—kidney cancer	0.00024	0.0176	CbGeAlD
Mitoxantrone—ABCG2—nephron tubule—kidney cancer	0.000232	0.017	CbGeAlD
Mitoxantrone—ABCC1—cardiac atrium—kidney cancer	0.000228	0.0168	CbGeAlD
Mitoxantrone—CYP2E1—nephron tubule—kidney cancer	0.000201	0.0148	CbGeAlD
Mitoxantrone—CYP2E1—renal system—kidney cancer	0.000182	0.0134	CbGeAlD
Mitoxantrone—CYP2E1—kidney—kidney cancer	0.000176	0.013	CbGeAlD
Mitoxantrone—CYP2E1—cortex of kidney—kidney cancer	0.000172	0.0126	CbGeAlD
Mitoxantrone—CYP3A4—renal system—kidney cancer	0.000147	0.0108	CbGeAlD
Mitoxantrone—CYP3A4—kidney—kidney cancer	0.000142	0.0104	CbGeAlD
Mitoxantrone—TOP2A—Vindesine—Vincristine—kidney cancer	0.000137	0.115	CbGdCrCtD
Mitoxantrone—TOP2A—Vindesine—Vinblastine—kidney cancer	0.000137	0.115	CbGdCrCtD
Mitoxantrone—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.000129	0.109	CbGdCrCtD
Mitoxantrone—ABCB1—nephron tubule—kidney cancer	0.000114	0.00841	CbGeAlD
Mitoxantrone—ABCB1—renal system—kidney cancer	0.000104	0.00764	CbGeAlD
Mitoxantrone—ABCB1—kidney—kidney cancer	0.0001	0.00739	CbGeAlD
Mitoxantrone—ABCB1—cortex of kidney—kidney cancer	9.78e-05	0.0072	CbGeAlD
Mitoxantrone—ABCB1—gonad—kidney cancer	9.32e-05	0.00685	CbGeAlD
Mitoxantrone—TOP2A—Vinorelbine—Vinblastine—kidney cancer	8.64e-05	0.0728	CbGdCrCtD
Mitoxantrone—TOP2A—Vinorelbine—Vincristine—kidney cancer	8.64e-05	0.0728	CbGdCrCtD
Mitoxantrone—TOP2A—Vincristine—Vinblastine—kidney cancer	7.39e-05	0.0623	CbGdCrCtD
Mitoxantrone—TOP2A—Vinblastine—Vincristine—kidney cancer	5.94e-05	0.0501	CbGdCrCtD
Mitoxantrone—TOP2A—Cytarabine—Gemcitabine—kidney cancer	4.86e-05	0.0409	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	4.17e-05	0.0351	CbGdCrCtD
Mitoxantrone—TOP2A—Epirubicin—Doxorubicin—kidney cancer	4.17e-05	0.0351	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Doxorubicin—kidney cancer	4.17e-05	0.0351	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Gemcitabine—kidney cancer	3.48e-05	0.0293	CbGdCrCtD
Mitoxantrone—Anorexia—Gemcitabine—kidney cancer	2.68e-05	0.000354	CcSEcCtD
Mitoxantrone—Vomiting—Vinblastine—kidney cancer	2.68e-05	0.000353	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Paclitaxel—kidney cancer	2.67e-05	0.000353	CcSEcCtD
Mitoxantrone—Vomiting—Everolimus—kidney cancer	2.66e-05	0.000352	CcSEcCtD
Mitoxantrone—Anaemia—Paclitaxel—kidney cancer	2.66e-05	0.000352	CcSEcCtD
Mitoxantrone—Paraesthesia—Vincristine—kidney cancer	2.66e-05	0.000351	CcSEcCtD
Mitoxantrone—Rash—Everolimus—kidney cancer	2.64e-05	0.000349	CcSEcCtD
Mitoxantrone—Dermatitis—Everolimus—kidney cancer	2.64e-05	0.000349	CcSEcCtD
Mitoxantrone—Headache—Vinblastine—kidney cancer	2.64e-05	0.000348	CcSEcCtD
Mitoxantrone—Headache—Everolimus—kidney cancer	2.63e-05	0.000347	CcSEcCtD
Mitoxantrone—Hypotension—Gemcitabine—kidney cancer	2.62e-05	0.000347	CcSEcCtD
Mitoxantrone—Abdominal pain—Dactinomycin—kidney cancer	2.62e-05	0.000346	CcSEcCtD
Mitoxantrone—Body temperature increased—Dactinomycin—kidney cancer	2.62e-05	0.000346	CcSEcCtD
Mitoxantrone—Anaphylactoid reaction—Doxorubicin—kidney cancer	2.62e-05	0.000345	CcSEcCtD
Mitoxantrone—Asthenia—Sorafenib—kidney cancer	2.61e-05	0.000345	CcSEcCtD
Mitoxantrone—Malaise—Paclitaxel—kidney cancer	2.6e-05	0.000343	CcSEcCtD
Mitoxantrone—Cardiac failure—Doxorubicin—kidney cancer	2.59e-05	0.000343	CcSEcCtD
Mitoxantrone—Leukopenia—Paclitaxel—kidney cancer	2.58e-05	0.000341	CcSEcCtD
Mitoxantrone—Hypersensitivity—Sunitinib—kidney cancer	2.58e-05	0.000341	CcSEcCtD
Mitoxantrone—Decreased appetite—Vincristine—kidney cancer	2.57e-05	0.00034	CcSEcCtD
Mitoxantrone—Vomiting—Erlotinib—kidney cancer	2.57e-05	0.00034	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	2.56e-05	0.000338	CcSEcCtD
Mitoxantrone—Fatigue—Vincristine—kidney cancer	2.55e-05	0.000337	CcSEcCtD
Mitoxantrone—Rash—Erlotinib—kidney cancer	2.55e-05	0.000337	CcSEcCtD
Mitoxantrone—Dermatitis—Erlotinib—kidney cancer	2.55e-05	0.000336	CcSEcCtD
Mitoxantrone—Hyponatraemia—Doxorubicin—kidney cancer	2.54e-05	0.000336	CcSEcCtD
Mitoxantrone—Headache—Erlotinib—kidney cancer	2.53e-05	0.000335	CcSEcCtD
Mitoxantrone—Constipation—Vincristine—kidney cancer	2.53e-05	0.000334	CcSEcCtD
Mitoxantrone—Pain—Vincristine—kidney cancer	2.53e-05	0.000334	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	2.53e-05	0.000334	CcSEcCtD
Mitoxantrone—Paraesthesia—Gemcitabine—kidney cancer	2.52e-05	0.000333	CcSEcCtD
Mitoxantrone—Cough—Paclitaxel—kidney cancer	2.51e-05	0.000332	CcSEcCtD
Mitoxantrone—Asthenia—Sunitinib—kidney cancer	2.51e-05	0.000332	CcSEcCtD
Mitoxantrone—Dyspnoea—Gemcitabine—kidney cancer	2.5e-05	0.000331	CcSEcCtD
Mitoxantrone—Nausea—Vinblastine—kidney cancer	2.5e-05	0.00033	CcSEcCtD
Mitoxantrone—Somnolence—Gemcitabine—kidney cancer	2.5e-05	0.00033	CcSEcCtD
Mitoxantrone—Convulsion—Paclitaxel—kidney cancer	2.5e-05	0.00033	CcSEcCtD
Mitoxantrone—Nausea—Everolimus—kidney cancer	2.49e-05	0.000329	CcSEcCtD
Mitoxantrone—Diarrhoea—Sorafenib—kidney cancer	2.49e-05	0.000329	CcSEcCtD
Mitoxantrone—Hypertension—Paclitaxel—kidney cancer	2.49e-05	0.000329	CcSEcCtD
Mitoxantrone—Arthralgia—Paclitaxel—kidney cancer	2.45e-05	0.000324	CcSEcCtD
Mitoxantrone—Chest pain—Paclitaxel—kidney cancer	2.45e-05	0.000324	CcSEcCtD
Mitoxantrone—Myalgia—Paclitaxel—kidney cancer	2.45e-05	0.000324	CcSEcCtD
Mitoxantrone—Anxiety—Paclitaxel—kidney cancer	2.44e-05	0.000323	CcSEcCtD
Mitoxantrone—Decreased appetite—Gemcitabine—kidney cancer	2.44e-05	0.000323	CcSEcCtD
Mitoxantrone—Hypersensitivity—Dactinomycin—kidney cancer	2.44e-05	0.000323	CcSEcCtD
Mitoxantrone—Chills—Capecitabine—kidney cancer	2.44e-05	0.000322	CcSEcCtD
Mitoxantrone—Arrhythmia—Capecitabine—kidney cancer	2.43e-05	0.000321	CcSEcCtD
Mitoxantrone—Discomfort—Paclitaxel—kidney cancer	2.42e-05	0.00032	CcSEcCtD
Mitoxantrone—Fatigue—Gemcitabine—kidney cancer	2.42e-05	0.00032	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Vincristine—kidney cancer	2.42e-05	0.00032	CcSEcCtD
Mitoxantrone—Pain—Gemcitabine—kidney cancer	2.4e-05	0.000317	CcSEcCtD
Mitoxantrone—Constipation—Gemcitabine—kidney cancer	2.4e-05	0.000317	CcSEcCtD
Mitoxantrone—Nausea—Erlotinib—kidney cancer	2.4e-05	0.000317	CcSEcCtD
Mitoxantrone—Alopecia—Capecitabine—kidney cancer	2.4e-05	0.000317	CcSEcCtD
Mitoxantrone—Diarrhoea—Sunitinib—kidney cancer	2.4e-05	0.000316	CcSEcCtD
Mitoxantrone—Asthenia—Dactinomycin—kidney cancer	2.38e-05	0.000314	CcSEcCtD
Mitoxantrone—Confusional state—Paclitaxel—kidney cancer	2.37e-05	0.000313	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Doxorubicin—kidney cancer	2.37e-05	0.000313	CcSEcCtD
Mitoxantrone—Erythema—Capecitabine—kidney cancer	2.36e-05	0.000312	CcSEcCtD
Mitoxantrone—Dehydration—Doxorubicin—kidney cancer	2.35e-05	0.000311	CcSEcCtD
Mitoxantrone—Oedema—Paclitaxel—kidney cancer	2.35e-05	0.000311	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Paclitaxel—kidney cancer	2.35e-05	0.000311	CcSEcCtD
Mitoxantrone—Abdominal pain—Vincristine—kidney cancer	2.34e-05	0.000309	CcSEcCtD
Mitoxantrone—Body temperature increased—Vincristine—kidney cancer	2.34e-05	0.000309	CcSEcCtD
Mitoxantrone—Infection—Paclitaxel—kidney cancer	2.34e-05	0.000309	CcSEcCtD
Mitoxantrone—Dysgeusia—Capecitabine—kidney cancer	2.32e-05	0.000306	CcSEcCtD
Mitoxantrone—Feeling abnormal—Gemcitabine—kidney cancer	2.31e-05	0.000306	CcSEcCtD
Mitoxantrone—Shock—Paclitaxel—kidney cancer	2.31e-05	0.000306	CcSEcCtD
Mitoxantrone—Vomiting—Sorafenib—kidney cancer	2.31e-05	0.000306	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Doxorubicin—kidney cancer	2.31e-05	0.000305	CcSEcCtD
Mitoxantrone—Hypokalaemia—Doxorubicin—kidney cancer	2.3e-05	0.000304	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Paclitaxel—kidney cancer	2.3e-05	0.000304	CcSEcCtD
Mitoxantrone—Tachycardia—Paclitaxel—kidney cancer	2.3e-05	0.000303	CcSEcCtD
Mitoxantrone—Rash—Sorafenib—kidney cancer	2.29e-05	0.000303	CcSEcCtD
Mitoxantrone—Dermatitis—Sorafenib—kidney cancer	2.29e-05	0.000303	CcSEcCtD
Mitoxantrone—Back pain—Capecitabine—kidney cancer	2.29e-05	0.000302	CcSEcCtD
Mitoxantrone—Skin disorder—Paclitaxel—kidney cancer	2.28e-05	0.000302	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	2.28e-05	0.000301	CcSEcCtD
Mitoxantrone—Headache—Sorafenib—kidney cancer	2.28e-05	0.000301	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Paclitaxel—kidney cancer	2.27e-05	0.0003	CcSEcCtD
Mitoxantrone—Diarrhoea—Dactinomycin—kidney cancer	2.27e-05	0.0003	CcSEcCtD
Mitoxantrone—Anorexia—Paclitaxel—kidney cancer	2.24e-05	0.000296	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	2.23e-05	0.000295	CcSEcCtD
Mitoxantrone—Vision blurred—Capecitabine—kidney cancer	2.23e-05	0.000294	CcSEcCtD
Mitoxantrone—Vomiting—Sunitinib—kidney cancer	2.23e-05	0.000294	CcSEcCtD
Mitoxantrone—Body temperature increased—Gemcitabine—kidney cancer	2.22e-05	0.000293	CcSEcCtD
Mitoxantrone—Rash—Sunitinib—kidney cancer	2.21e-05	0.000292	CcSEcCtD
Mitoxantrone—Dermatitis—Sunitinib—kidney cancer	2.21e-05	0.000291	CcSEcCtD
Mitoxantrone—Hypotension—Paclitaxel—kidney cancer	2.2e-05	0.00029	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Capecitabine—kidney cancer	2.19e-05	0.00029	CcSEcCtD
Mitoxantrone—Headache—Sunitinib—kidney cancer	2.19e-05	0.00029	CcSEcCtD
Mitoxantrone—Anaemia—Capecitabine—kidney cancer	2.19e-05	0.000289	CcSEcCtD
Mitoxantrone—Hypersensitivity—Vincristine—kidney cancer	2.18e-05	0.000288	CcSEcCtD
Mitoxantrone—Nausea—Sorafenib—kidney cancer	2.16e-05	0.000285	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.14e-05	0.000283	CcSEcCtD
Mitoxantrone—Malaise—Capecitabine—kidney cancer	2.13e-05	0.000282	CcSEcCtD
Mitoxantrone—Asthenia—Vincristine—kidney cancer	2.12e-05	0.000281	CcSEcCtD
Mitoxantrone—Leukopenia—Capecitabine—kidney cancer	2.12e-05	0.00028	CcSEcCtD
Mitoxantrone—Paraesthesia—Paclitaxel—kidney cancer	2.11e-05	0.000279	CcSEcCtD
Mitoxantrone—Vomiting—Dactinomycin—kidney cancer	2.11e-05	0.000278	CcSEcCtD
Mitoxantrone—Dyspnoea—Paclitaxel—kidney cancer	2.1e-05	0.000277	CcSEcCtD
Mitoxantrone—Somnolence—Paclitaxel—kidney cancer	2.09e-05	0.000276	CcSEcCtD
Mitoxantrone—Rash—Dactinomycin—kidney cancer	2.09e-05	0.000276	CcSEcCtD
Mitoxantrone—Nausea—Sunitinib—kidney cancer	2.08e-05	0.000275	CcSEcCtD
Mitoxantrone—Pancytopenia—Doxorubicin—kidney cancer	2.08e-05	0.000274	CcSEcCtD
Mitoxantrone—Dyspepsia—Paclitaxel—kidney cancer	2.07e-05	0.000273	CcSEcCtD
Mitoxantrone—Cough—Capecitabine—kidney cancer	2.06e-05	0.000273	CcSEcCtD
Mitoxantrone—Neutropenia—Doxorubicin—kidney cancer	2.05e-05	0.00027	CcSEcCtD
Mitoxantrone—Decreased appetite—Paclitaxel—kidney cancer	2.04e-05	0.00027	CcSEcCtD
Mitoxantrone—Hypertension—Capecitabine—kidney cancer	2.04e-05	0.00027	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Doxorubicin—kidney cancer	2.03e-05	0.000269	CcSEcCtD
Mitoxantrone—Fatigue—Paclitaxel—kidney cancer	2.03e-05	0.000268	CcSEcCtD
Mitoxantrone—Diarrhoea—Vincristine—kidney cancer	2.03e-05	0.000268	CcSEcCtD
Mitoxantrone—Asthenia—Gemcitabine—kidney cancer	2.02e-05	0.000266	CcSEcCtD
Mitoxantrone—Arthralgia—Capecitabine—kidney cancer	2.01e-05	0.000266	CcSEcCtD
Mitoxantrone—Chest pain—Capecitabine—kidney cancer	2.01e-05	0.000266	CcSEcCtD
Mitoxantrone—Myalgia—Capecitabine—kidney cancer	2.01e-05	0.000266	CcSEcCtD
Mitoxantrone—Constipation—Paclitaxel—kidney cancer	2.01e-05	0.000266	CcSEcCtD
Mitoxantrone—Pain—Paclitaxel—kidney cancer	2.01e-05	0.000266	CcSEcCtD
Mitoxantrone—Anxiety—Capecitabine—kidney cancer	2.01e-05	0.000265	CcSEcCtD
Mitoxantrone—Weight increased—Doxorubicin—kidney cancer	1.99e-05	0.000263	CcSEcCtD
Mitoxantrone—Discomfort—Capecitabine—kidney cancer	1.99e-05	0.000263	CcSEcCtD
Mitoxantrone—Weight decreased—Doxorubicin—kidney cancer	1.98e-05	0.000261	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Doxorubicin—kidney cancer	1.97e-05	0.000261	CcSEcCtD
Mitoxantrone—Nausea—Dactinomycin—kidney cancer	1.97e-05	0.00026	CcSEcCtD
Mitoxantrone—Pneumonia—Doxorubicin—kidney cancer	1.96e-05	0.000259	CcSEcCtD
Mitoxantrone—Drowsiness—Doxorubicin—kidney cancer	1.95e-05	0.000258	CcSEcCtD
Mitoxantrone—Confusional state—Capecitabine—kidney cancer	1.95e-05	0.000257	CcSEcCtD
Mitoxantrone—Feeling abnormal—Paclitaxel—kidney cancer	1.94e-05	0.000256	CcSEcCtD
Mitoxantrone—Oedema—Capecitabine—kidney cancer	1.93e-05	0.000255	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Paclitaxel—kidney cancer	1.92e-05	0.000254	CcSEcCtD
Mitoxantrone—Diarrhoea—Gemcitabine—kidney cancer	1.92e-05	0.000254	CcSEcCtD
Mitoxantrone—Renal failure—Doxorubicin—kidney cancer	1.92e-05	0.000253	CcSEcCtD
Mitoxantrone—Infection—Capecitabine—kidney cancer	1.92e-05	0.000253	CcSEcCtD
Mitoxantrone—Jaundice—Doxorubicin—kidney cancer	1.9e-05	0.000251	CcSEcCtD
Mitoxantrone—Stomatitis—Doxorubicin—kidney cancer	1.9e-05	0.000251	CcSEcCtD
Mitoxantrone—Shock—Capecitabine—kidney cancer	1.9e-05	0.000251	CcSEcCtD
Mitoxantrone—Conjunctivitis—Doxorubicin—kidney cancer	1.9e-05	0.00025	CcSEcCtD
Mitoxantrone—Urinary tract infection—Doxorubicin—kidney cancer	1.9e-05	0.00025	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Capecitabine—kidney cancer	1.89e-05	0.00025	CcSEcCtD
Mitoxantrone—Tachycardia—Capecitabine—kidney cancer	1.88e-05	0.000249	CcSEcCtD
Mitoxantrone—Vomiting—Vincristine—kidney cancer	1.88e-05	0.000249	CcSEcCtD
Mitoxantrone—Skin disorder—Capecitabine—kidney cancer	1.87e-05	0.000248	CcSEcCtD
Mitoxantrone—Sweating—Doxorubicin—kidney cancer	1.87e-05	0.000247	CcSEcCtD
Mitoxantrone—Urticaria—Paclitaxel—kidney cancer	1.87e-05	0.000247	CcSEcCtD
Mitoxantrone—Rash—Vincristine—kidney cancer	1.87e-05	0.000247	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Capecitabine—kidney cancer	1.87e-05	0.000246	CcSEcCtD
Mitoxantrone—Dermatitis—Vincristine—kidney cancer	1.87e-05	0.000246	CcSEcCtD
Mitoxantrone—Haematuria—Doxorubicin—kidney cancer	1.86e-05	0.000246	CcSEcCtD
Mitoxantrone—Abdominal pain—Paclitaxel—kidney cancer	1.86e-05	0.000246	CcSEcCtD
Mitoxantrone—Body temperature increased—Paclitaxel—kidney cancer	1.86e-05	0.000246	CcSEcCtD
Mitoxantrone—Headache—Vincristine—kidney cancer	1.86e-05	0.000245	CcSEcCtD
Mitoxantrone—Anorexia—Capecitabine—kidney cancer	1.84e-05	0.000243	CcSEcCtD
Mitoxantrone—Sinusitis—Doxorubicin—kidney cancer	1.83e-05	0.000242	CcSEcCtD
Mitoxantrone—Agranulocytosis—Doxorubicin—kidney cancer	1.82e-05	0.00024	CcSEcCtD
Mitoxantrone—Hypotension—Capecitabine—kidney cancer	1.8e-05	0.000238	CcSEcCtD
Mitoxantrone—Vomiting—Gemcitabine—kidney cancer	1.79e-05	0.000236	CcSEcCtD
Mitoxantrone—Bradycardia—Doxorubicin—kidney cancer	1.78e-05	0.000235	CcSEcCtD
Mitoxantrone—Rash—Gemcitabine—kidney cancer	1.77e-05	0.000234	CcSEcCtD
Mitoxantrone—Dermatitis—Gemcitabine—kidney cancer	1.77e-05	0.000234	CcSEcCtD
Mitoxantrone—Haemoglobin—Doxorubicin—kidney cancer	1.76e-05	0.000232	CcSEcCtD
Mitoxantrone—Headache—Gemcitabine—kidney cancer	1.76e-05	0.000232	CcSEcCtD
Mitoxantrone—Nausea—Vincristine—kidney cancer	1.76e-05	0.000232	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.76e-05	0.000232	CcSEcCtD
Mitoxantrone—Rhinitis—Doxorubicin—kidney cancer	1.76e-05	0.000232	CcSEcCtD
Mitoxantrone—Haemorrhage—Doxorubicin—kidney cancer	1.75e-05	0.000231	CcSEcCtD
Mitoxantrone—Hepatitis—Doxorubicin—kidney cancer	1.75e-05	0.000231	CcSEcCtD
Mitoxantrone—Pharyngitis—Doxorubicin—kidney cancer	1.74e-05	0.00023	CcSEcCtD
Mitoxantrone—Paraesthesia—Capecitabine—kidney cancer	1.73e-05	0.000229	CcSEcCtD
Mitoxantrone—Hypersensitivity—Paclitaxel—kidney cancer	1.73e-05	0.000229	CcSEcCtD
Mitoxantrone—Dyspnoea—Capecitabine—kidney cancer	1.72e-05	0.000227	CcSEcCtD
Mitoxantrone—Dyspepsia—Capecitabine—kidney cancer	1.7e-05	0.000224	CcSEcCtD
Mitoxantrone—Asthenia—Paclitaxel—kidney cancer	1.69e-05	0.000223	CcSEcCtD
Mitoxantrone—Decreased appetite—Capecitabine—kidney cancer	1.68e-05	0.000222	CcSEcCtD
Mitoxantrone—Nausea—Gemcitabine—kidney cancer	1.67e-05	0.00022	CcSEcCtD
Mitoxantrone—Fatigue—Capecitabine—kidney cancer	1.66e-05	0.00022	CcSEcCtD
Mitoxantrone—Pain—Capecitabine—kidney cancer	1.65e-05	0.000218	CcSEcCtD
Mitoxantrone—Constipation—Capecitabine—kidney cancer	1.65e-05	0.000218	CcSEcCtD
Mitoxantrone—Diarrhoea—Paclitaxel—kidney cancer	1.61e-05	0.000213	CcSEcCtD
Mitoxantrone—Feeling abnormal—Capecitabine—kidney cancer	1.59e-05	0.00021	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Capecitabine—kidney cancer	1.58e-05	0.000208	CcSEcCtD
Mitoxantrone—Chills—Doxorubicin—kidney cancer	1.57e-05	0.000208	CcSEcCtD
Mitoxantrone—Arrhythmia—Doxorubicin—kidney cancer	1.56e-05	0.000207	CcSEcCtD
Mitoxantrone—Alopecia—Doxorubicin—kidney cancer	1.55e-05	0.000204	CcSEcCtD
Mitoxantrone—Urticaria—Capecitabine—kidney cancer	1.53e-05	0.000203	CcSEcCtD
Mitoxantrone—Body temperature increased—Capecitabine—kidney cancer	1.53e-05	0.000202	CcSEcCtD
Mitoxantrone—Abdominal pain—Capecitabine—kidney cancer	1.53e-05	0.000202	CcSEcCtD
Mitoxantrone—Erythema—Doxorubicin—kidney cancer	1.52e-05	0.000201	CcSEcCtD
Mitoxantrone—Vomiting—Paclitaxel—kidney cancer	1.5e-05	0.000198	CcSEcCtD
Mitoxantrone—Dysgeusia—Doxorubicin—kidney cancer	1.49e-05	0.000197	CcSEcCtD
Mitoxantrone—Rash—Paclitaxel—kidney cancer	1.48e-05	0.000196	CcSEcCtD
Mitoxantrone—Dermatitis—Paclitaxel—kidney cancer	1.48e-05	0.000196	CcSEcCtD
Mitoxantrone—Back pain—Doxorubicin—kidney cancer	1.47e-05	0.000195	CcSEcCtD
Mitoxantrone—Headache—Paclitaxel—kidney cancer	1.47e-05	0.000195	CcSEcCtD
Mitoxantrone—Vision blurred—Doxorubicin—kidney cancer	1.44e-05	0.00019	CcSEcCtD
Mitoxantrone—Hypersensitivity—Capecitabine—kidney cancer	1.42e-05	0.000188	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Doxorubicin—kidney cancer	1.41e-05	0.000187	CcSEcCtD
Mitoxantrone—Anaemia—Doxorubicin—kidney cancer	1.41e-05	0.000186	CcSEcCtD
Mitoxantrone—Nausea—Paclitaxel—kidney cancer	1.4e-05	0.000185	CcSEcCtD
Mitoxantrone—Asthenia—Capecitabine—kidney cancer	1.38e-05	0.000183	CcSEcCtD
Mitoxantrone—Malaise—Doxorubicin—kidney cancer	1.37e-05	0.000182	CcSEcCtD
Mitoxantrone—Leukopenia—Doxorubicin—kidney cancer	1.36e-05	0.00018	CcSEcCtD
Mitoxantrone—Cough—Doxorubicin—kidney cancer	1.33e-05	0.000176	CcSEcCtD
Mitoxantrone—Convulsion—Doxorubicin—kidney cancer	1.32e-05	0.000174	CcSEcCtD
Mitoxantrone—Diarrhoea—Capecitabine—kidney cancer	1.32e-05	0.000174	CcSEcCtD
Mitoxantrone—Hypertension—Doxorubicin—kidney cancer	1.32e-05	0.000174	CcSEcCtD
Mitoxantrone—Arthralgia—Doxorubicin—kidney cancer	1.3e-05	0.000171	CcSEcCtD
Mitoxantrone—Chest pain—Doxorubicin—kidney cancer	1.3e-05	0.000171	CcSEcCtD
Mitoxantrone—Myalgia—Doxorubicin—kidney cancer	1.3e-05	0.000171	CcSEcCtD
Mitoxantrone—Anxiety—Doxorubicin—kidney cancer	1.29e-05	0.000171	CcSEcCtD
Mitoxantrone—Discomfort—Doxorubicin—kidney cancer	1.28e-05	0.000169	CcSEcCtD
Mitoxantrone—Confusional state—Doxorubicin—kidney cancer	1.25e-05	0.000166	CcSEcCtD
Mitoxantrone—Oedema—Doxorubicin—kidney cancer	1.24e-05	0.000164	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Doxorubicin—kidney cancer	1.24e-05	0.000164	CcSEcCtD
Mitoxantrone—Infection—Doxorubicin—kidney cancer	1.24e-05	0.000163	CcSEcCtD
Mitoxantrone—Vomiting—Capecitabine—kidney cancer	1.23e-05	0.000162	CcSEcCtD
Mitoxantrone—Shock—Doxorubicin—kidney cancer	1.22e-05	0.000162	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Doxorubicin—kidney cancer	1.22e-05	0.000161	CcSEcCtD
Mitoxantrone—Rash—Capecitabine—kidney cancer	1.22e-05	0.000161	CcSEcCtD
Mitoxantrone—Dermatitis—Capecitabine—kidney cancer	1.22e-05	0.000161	CcSEcCtD
Mitoxantrone—Tachycardia—Doxorubicin—kidney cancer	1.21e-05	0.00016	CcSEcCtD
Mitoxantrone—Headache—Capecitabine—kidney cancer	1.21e-05	0.00016	CcSEcCtD
Mitoxantrone—Skin disorder—Doxorubicin—kidney cancer	1.21e-05	0.00016	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Doxorubicin—kidney cancer	1.2e-05	0.000159	CcSEcCtD
Mitoxantrone—Anorexia—Doxorubicin—kidney cancer	1.19e-05	0.000157	CcSEcCtD
Mitoxantrone—Hypotension—Doxorubicin—kidney cancer	1.16e-05	0.000154	CcSEcCtD
Mitoxantrone—Nausea—Capecitabine—kidney cancer	1.15e-05	0.000151	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.13e-05	0.00015	CcSEcCtD
Mitoxantrone—Paraesthesia—Doxorubicin—kidney cancer	1.12e-05	0.000148	CcSEcCtD
Mitoxantrone—Dyspnoea—Doxorubicin—kidney cancer	1.11e-05	0.000147	CcSEcCtD
Mitoxantrone—Somnolence—Doxorubicin—kidney cancer	1.11e-05	0.000146	CcSEcCtD
Mitoxantrone—Dyspepsia—Doxorubicin—kidney cancer	1.1e-05	0.000145	CcSEcCtD
Mitoxantrone—Decreased appetite—Doxorubicin—kidney cancer	1.08e-05	0.000143	CcSEcCtD
Mitoxantrone—Fatigue—Doxorubicin—kidney cancer	1.07e-05	0.000142	CcSEcCtD
Mitoxantrone—Pain—Doxorubicin—kidney cancer	1.06e-05	0.000141	CcSEcCtD
Mitoxantrone—Constipation—Doxorubicin—kidney cancer	1.06e-05	0.000141	CcSEcCtD
Mitoxantrone—Feeling abnormal—Doxorubicin—kidney cancer	1.03e-05	0.000135	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Doxorubicin—kidney cancer	1.02e-05	0.000134	CcSEcCtD
Mitoxantrone—Urticaria—Doxorubicin—kidney cancer	9.88e-06	0.000131	CcSEcCtD
Mitoxantrone—Abdominal pain—Doxorubicin—kidney cancer	9.84e-06	0.00013	CcSEcCtD
Mitoxantrone—Body temperature increased—Doxorubicin—kidney cancer	9.84e-06	0.00013	CcSEcCtD
Mitoxantrone—Hypersensitivity—Doxorubicin—kidney cancer	9.17e-06	0.000121	CcSEcCtD
Mitoxantrone—Asthenia—Doxorubicin—kidney cancer	8.93e-06	0.000118	CcSEcCtD
Mitoxantrone—Diarrhoea—Doxorubicin—kidney cancer	8.51e-06	0.000112	CcSEcCtD
Mitoxantrone—Vomiting—Doxorubicin—kidney cancer	7.91e-06	0.000104	CcSEcCtD
Mitoxantrone—Rash—Doxorubicin—kidney cancer	7.84e-06	0.000104	CcSEcCtD
Mitoxantrone—Dermatitis—Doxorubicin—kidney cancer	7.84e-06	0.000104	CcSEcCtD
Mitoxantrone—Headache—Doxorubicin—kidney cancer	7.79e-06	0.000103	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism—CA9—kidney cancer	7.45e-06	0.000243	CbGpPWpGaD
Mitoxantrone—Nausea—Doxorubicin—kidney cancer	7.39e-06	9.76e-05	CcSEcCtD
Mitoxantrone—CYP2E1—Metabolism—GLIPR1—kidney cancer	7.31e-06	0.000238	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPAT—kidney cancer	7.31e-06	0.000238	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KIT—kidney cancer	7.3e-06	0.000238	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.29e-06	0.000237	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CA9—kidney cancer	7.21e-06	0.000235	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—MAPK3—kidney cancer	7.09e-06	0.000231	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.05e-06	0.00023	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ITPR2—kidney cancer	7.04e-06	0.000229	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN2A—kidney cancer	6.94e-06	0.000226	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	6.87e-06	0.000224	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—FH—kidney cancer	6.79e-06	0.000221	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APRT—kidney cancer	6.79e-06	0.000221	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PDHB—kidney cancer	6.75e-06	0.00022	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—MAPK1—kidney cancer	6.75e-06	0.00022	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDH1—kidney cancer	6.72e-06	0.000219	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.62e-06	0.000216	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CA9—kidney cancer	6.56e-06	0.000214	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	6.56e-06	0.000214	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	6.5e-06	0.000212	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPC3—kidney cancer	6.39e-06	0.000208	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	6.38e-06	0.000208	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—KRAS—kidney cancer	6.38e-06	0.000208	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CCBL1—kidney cancer	6.35e-06	0.000207	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CRABP1—kidney cancer	6.34e-06	0.000207	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	6.3e-06	0.000205	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CA2—kidney cancer	6.21e-06	0.000202	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN1B—kidney cancer	6.15e-06	0.0002	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CRABP1—kidney cancer	6.13e-06	0.0002	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KRAS—kidney cancer	6.12e-06	0.000199	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALAD—kidney cancer	6.06e-06	0.000197	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ST3GAL2—kidney cancer	5.91e-06	0.000193	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PSMD7—kidney cancer	5.9e-06	0.000192	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ITPR2—kidney cancer	5.89e-06	0.000192	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.87e-06	0.000191	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CCND1—kidney cancer	5.86e-06	0.000191	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PIK3CA—kidney cancer	5.86e-06	0.000191	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	5.79e-06	0.000189	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALDH1A1—kidney cancer	5.78e-06	0.000188	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RAF1—kidney cancer	5.73e-06	0.000187	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RELA—kidney cancer	5.71e-06	0.000186	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ITPR2—kidney cancer	5.7e-06	0.000186	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB2—kidney cancer	5.67e-06	0.000185	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CA—kidney cancer	5.62e-06	0.000183	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MTOR—kidney cancer	5.6e-06	0.000182	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD4—kidney cancer	5.59e-06	0.000182	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CRABP1—kidney cancer	5.58e-06	0.000182	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	5.56e-06	0.000181	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC5A3—kidney cancer	5.54e-06	0.00018	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PGK1—kidney cancer	5.54e-06	0.00018	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPAT—kidney cancer	5.5e-06	0.000179	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GLIPR1—kidney cancer	5.5e-06	0.000179	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	5.48e-06	0.000179	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.43e-06	0.000177	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—LDHB—kidney cancer	5.43e-06	0.000177	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	5.41e-06	0.000176	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTT1—kidney cancer	5.37e-06	0.000175	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ACHE—kidney cancer	5.37e-06	0.000175	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SLC2A1—kidney cancer	5.33e-06	0.000174	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JUNB—kidney cancer	5.29e-06	0.000172	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	5.26e-06	0.000171	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.25e-06	0.000171	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1B—kidney cancer	5.25e-06	0.000171	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTT1—kidney cancer	5.2e-06	0.000169	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ACHE—kidney cancer	5.2e-06	0.000169	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ITPR2—kidney cancer	5.18e-06	0.000169	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	5.15e-06	0.000168	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2—kidney cancer	5.14e-06	0.000167	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APRT—kidney cancer	5.12e-06	0.000167	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—FH—kidney cancer	5.12e-06	0.000167	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	5.1e-06	0.000166	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SCARB1—kidney cancer	5.09e-06	0.000166	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	5.05e-06	0.000164	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS1—kidney cancer	5.04e-06	0.000164	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—JUN—kidney cancer	5e-06	0.000163	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CTNNB1—kidney cancer	4.96e-06	0.000162	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PSMD7—kidney cancer	4.94e-06	0.000161	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	4.94e-06	0.000161	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SCARB1—kidney cancer	4.92e-06	0.00016	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ACY1—kidney cancer	4.89e-06	0.000159	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS1—kidney cancer	4.87e-06	0.000159	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PTEN—kidney cancer	4.84e-06	0.000158	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MAPK3—kidney cancer	4.84e-06	0.000158	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPC3—kidney cancer	4.81e-06	0.000157	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PSMD7—kidney cancer	4.78e-06	0.000156	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTT1—kidney cancer	4.73e-06	0.000154	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ACHE—kidney cancer	4.73e-06	0.000154	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CA9—kidney cancer	4.71e-06	0.000153	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—kidney cancer	4.7e-06	0.000153	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.7e-06	0.000153	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—BCHE—kidney cancer	4.68e-06	0.000153	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA2—kidney cancer	4.68e-06	0.000152	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.68e-06	0.000152	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC5A5—kidney cancer	4.62e-06	0.000151	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MAPK1—kidney cancer	4.6e-06	0.00015	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALAD—kidney cancer	4.56e-06	0.000149	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.54e-06	0.000148	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—BCHE—kidney cancer	4.53e-06	0.000148	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SCARB1—kidney cancer	4.48e-06	0.000146	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC5A5—kidney cancer	4.47e-06	0.000146	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC2A1—kidney cancer	4.47e-06	0.000146	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.46e-06	0.000145	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ST3GAL2—kidney cancer	4.45e-06	0.000145	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.45e-06	0.000145	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS1—kidney cancer	4.43e-06	0.000144	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.42e-06	0.000144	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALDH1A1—kidney cancer	4.35e-06	0.000142	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PSMD7—kidney cancer	4.34e-06	0.000142	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.33e-06	0.000141	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC2A1—kidney cancer	4.32e-06	0.000141	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN2B—kidney cancer	4.31e-06	0.00014	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.3e-06	0.00014	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.26e-06	0.000139	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.19e-06	0.000137	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PGK1—kidney cancer	4.17e-06	0.000136	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC5A3—kidney cancer	4.17e-06	0.000136	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PDHB—kidney cancer	4.16e-06	0.000136	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—POMC—kidney cancer	4.15e-06	0.000135	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK3—kidney cancer	4.13e-06	0.000135	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—BCHE—kidney cancer	4.12e-06	0.000134	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LDHB—kidney cancer	4.09e-06	0.000133	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC5A5—kidney cancer	4.07e-06	0.000133	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CRABP1—kidney cancer	4e-06	0.00013	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK1—kidney cancer	3.93e-06	0.000128	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC2A1—kidney cancer	3.93e-06	0.000128	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CCBL1—kidney cancer	3.91e-06	0.000127	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.89e-06	0.000127	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—kidney cancer	3.86e-06	0.000126	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.78e-06	0.000123	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.75e-06	0.000122	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTP1—kidney cancer	3.72e-06	0.000121	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ITPR2—kidney cancer	3.72e-06	0.000121	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—kidney cancer	3.71e-06	0.000121	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.68e-06	0.00012	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.65e-06	0.000119	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTP1—kidney cancer	3.6e-06	0.000117	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.58e-06	0.000117	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA9—kidney cancer	3.55e-06	0.000116	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCB1—kidney cancer	3.53e-06	0.000115	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.5e-06	0.000114	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HIF1A—kidney cancer	3.44e-06	0.000112	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TSC2—kidney cancer	3.44e-06	0.000112	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTM1—kidney cancer	3.42e-06	0.000112	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—kidney cancer	3.41e-06	0.000111	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCB1—kidney cancer	3.41e-06	0.000111	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTT1—kidney cancer	3.39e-06	0.000111	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ACHE—kidney cancer	3.39e-06	0.000111	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPAT—kidney cancer	3.39e-06	0.00011	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.39e-06	0.00011	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTM1—kidney cancer	3.31e-06	0.000108	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.31e-06	0.000108	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTP1—kidney cancer	3.28e-06	0.000107	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1A1—kidney cancer	3.24e-06	0.000106	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SCARB1—kidney cancer	3.21e-06	0.000105	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS1—kidney cancer	3.18e-06	0.000104	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FH—kidney cancer	3.15e-06	0.000103	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APRT—kidney cancer	3.15e-06	0.000103	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP1A1—kidney cancer	3.14e-06	0.000102	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PSMD7—kidney cancer	3.12e-06	0.000102	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCB1—kidney cancer	3.1e-06	0.000101	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.04e-06	9.9e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KIT—kidney cancer	3.03e-06	9.89e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APC—kidney cancer	3.03e-06	9.89e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CRABP1—kidney cancer	3.02e-06	9.83e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTM1—kidney cancer	3.01e-06	9.81e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPC3—kidney cancer	2.96e-06	9.66e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—BCHE—kidney cancer	2.96e-06	9.64e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.94e-06	9.57e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC5A5—kidney cancer	2.92e-06	9.52e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA2—kidney cancer	2.88e-06	9.39e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1A1—kidney cancer	2.86e-06	9.3e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BRAF—kidney cancer	2.85e-06	9.29e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC2A1—kidney cancer	2.82e-06	9.19e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALAD—kidney cancer	2.81e-06	9.15e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ITPR2—kidney cancer	2.8e-06	9.13e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.74e-06	8.94e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.68e-06	8.73e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.67e-06	8.69e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.58e-06	8.4e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PGK1—kidney cancer	2.57e-06	8.37e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.57e-06	8.37e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTT1—kidney cancer	2.56e-06	8.33e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ACHE—kidney cancer	2.56e-06	8.33e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LDHB—kidney cancer	2.52e-06	8.21e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SCARB1—kidney cancer	2.42e-06	7.88e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—POMC—kidney cancer	2.42e-06	7.88e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS1—kidney cancer	2.4e-06	7.81e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RAF1—kidney cancer	2.38e-06	7.76e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB2—kidney cancer	2.36e-06	7.68e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTP1—kidney cancer	2.35e-06	7.67e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PSMD7—kidney cancer	2.35e-06	7.65e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—POMC—kidney cancer	2.34e-06	7.62e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTOR—kidney cancer	2.33e-06	7.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD4—kidney cancer	2.32e-06	7.56e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—kidney cancer	2.3e-06	7.51e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCB1—kidney cancer	2.23e-06	7.26e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BCHE—kidney cancer	2.23e-06	7.26e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC5A5—kidney cancer	2.2e-06	7.17e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA9—kidney cancer	2.18e-06	7.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1B—kidney cancer	2.18e-06	7.11e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTM1—kidney cancer	2.16e-06	7.05e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—POMC—kidney cancer	2.13e-06	6.94e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A1—kidney cancer	2.12e-06	6.92e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CTNNB1—kidney cancer	2.06e-06	6.72e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1A1—kidney cancer	2.05e-06	6.68e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.03e-06	6.6e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTEN—kidney cancer	2.01e-06	6.55e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—kidney cancer	1.93e-06	6.29e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—kidney cancer	1.87e-06	6.08e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CRABP1—kidney cancer	1.86e-06	6.05e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTP1—kidney cancer	1.77e-06	5.77e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ITPR2—kidney cancer	1.73e-06	5.63e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK3—kidney cancer	1.72e-06	5.59e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—kidney cancer	1.7e-06	5.53e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTEN—kidney cancer	1.68e-06	5.48e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—kidney cancer	1.67e-06	5.44e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK1—kidney cancer	1.63e-06	5.32e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTM1—kidney cancer	1.63e-06	5.31e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTEN—kidney cancer	1.63e-06	5.3e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTT1—kidney cancer	1.57e-06	5.13e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ACHE—kidney cancer	1.57e-06	5.13e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1A1—kidney cancer	1.54e-06	5.03e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—kidney cancer	1.54e-06	5.03e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—POMC—kidney cancer	1.53e-06	4.98e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SCARB1—kidney cancer	1.49e-06	4.86e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTEN—kidney cancer	1.48e-06	4.82e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS1—kidney cancer	1.48e-06	4.81e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PSMD7—kidney cancer	1.45e-06	4.72e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—kidney cancer	1.42e-06	4.62e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BCHE—kidney cancer	1.37e-06	4.47e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.36e-06	4.42e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.31e-06	4.26e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—kidney cancer	1.22e-06	3.97e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—kidney cancer	1.19e-06	3.87e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—POMC—kidney cancer	1.15e-06	3.75e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—kidney cancer	1.15e-06	3.74e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTP1—kidney cancer	1.09e-06	3.56e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTEN—kidney cancer	1.06e-06	3.46e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—kidney cancer	1.04e-06	3.4e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCB1—kidney cancer	1.03e-06	3.37e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM1—kidney cancer	1e-06	3.27e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1A1—kidney cancer	9.51e-07	3.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—kidney cancer	9.18e-07	2.99e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTEN—kidney cancer	8.01e-07	2.61e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—kidney cancer	7.5e-07	2.44e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—POMC—kidney cancer	7.09e-07	2.31e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—kidney cancer	5.66e-07	1.84e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—kidney cancer	5.65e-07	1.84e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTEN—kidney cancer	4.93e-07	1.61e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.48e-07	1.13e-05	CbGpPWpGaD
